全球智库信息集成服务系统(G2TT): Preferred Pharmacy Networks and Drug Costs

G2TT

来源类型	Working Paper
规范类型	报告
DOI	10.3386/w24862
来源ID	Working Paper 24862
	Preferred Pharmacy Networks and Drug Costs
	Amanda Starc; Ashley Swanson
发表日期	2018-07-30
出版年	2018
语种	英语
摘要	Selective contracting is an increasingly popular tool for reducing health care costs, but these savings must be weighed against consumer surplus losses from restricted access. In both public and private prescription drug insurance plans, issuers utilize preferred pharmacy networks to reduce drug prices. We show that, in the Medicare Part D program, drug plans with more restrictive preferred pharmacy networks, and plans with fewer enrollees who are insensitive to preferred pharmacy discounts on copays, pay lower retail drug prices. We then use estimates of plan and pharmacy demand to estimate the first-order costs and benefits of selective contracting in the presence of enrollees with heterogeneous sensitivity to preferred supplier incentives.
主题	Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance
URL	https://www.nber.org/papers/w24862
来源智库	National Bureau of Economic Research (United States)
引用统计
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/582536
推荐引用方式 GB/T 7714	Amanda Starc,Ashley Swanson. Preferred Pharmacy Networks and Drug Costs. 2018.